Olumiant (baricitinib): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1564492295

Medication indications

Olumiant 2 mg and 4 mg Film-Coated Tablets

Olumiant is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Olumiant may be used as monotherapy or in combination with methotrexate (see sections 4.4, 4.5 and 5.1 for available data on different combinations).


Route of administration: Oral
Molecule: baricitinib

Patients' opinions on Olumiant

In brief

General satisfaction level: 5.25/10 Learn more

Treatment's effectiveness: 8.00/10 Learn more

Ease of use: 10.00/10 Learn more

Adherence to prescription: 7.75/10 Learn more

Detected side effects: 1.00/10 Learn more

Improvement in the quality of life: 6.75/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community


avatar
DonnaW
on 30/01/2021

Pain has eased at first full of energy and felt brilliant. One year on and the weight gain is ridiculous and feel sluggish tired and pain returning. Not a happy bunny. 

Your message


avatar
DonnaW
on 16/11/2020

Weight gain a major problem but pain relief is brilliant. Have to weigh up pain or weight. Pain relief wins with me 

Your message


avatar
moosue
on 21/02/2019

  Don’t give up don’t give in. It’s taken me 10 years to get those four thumbs up .

Your message

Conditions related to this medication

See the fact sheet